Ten years' disease-free survival of advanced epithelial ovarian cancer treated by cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy A case report and literature review

被引:2
|
作者
Zhang, Jue [1 ]
Mei, Liejun [2 ]
Wang, Fubing [3 ]
Li, Yan [1 ]
机构
[1] Capital Med Univ, Beijing Shijitan Hosp, Dept Peritoneal Canc Surg, 10 Tieyi Rd,Yangfangdian St, Beijing 100038, Peoples R China
[2] Wuhan Univ, Zhongnan Hosp, Dept Radiol, Wuhan 430071, Peoples R China
[3] Wuhan Univ, Zhongnan Hosp, Dept Clin Lab, Wuhan 430071, Peoples R China
基金
北京市自然科学基金;
关键词
advanced ovarian cancer; cytoreductive surgery; hyperthermic intraperitoneal chemotherapy; peritoneal carcinomatosis; HIPEC; PACLITAXEL; CISPLATIN;
D O I
10.1097/MD.0000000000023404
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Rationale: One of the most distinctive features of epithelial ovarian cancer is tendency to disseminate into peritoneal cavity to form peritoneal carcinomatosis, indicating advanced disease with poor prognosis. Patient concerns: A fifty-year-old patient had a chief complaint of an abdominal distension lasting 1 month. Diagnoses: The patient was diagnosed with advanced epithelial ovarian cancer with peritoneal carcinomatosis by computed tomography scan, tumor markers, endoscopy examination, and pathology. Interventions: The patient was treated with cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy followed by 8 cycles of systemic chemotherapy. Outcomes: Till March 9, 2020, the patient has disease-free survival over 10 years. Lessons: The application of cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy combined with systematic chemotherapy may improve survival dramatically for the patients with epithelial ovarian cancer and peritoneal carcinomatosis and should be considered as an option of a relatively new regime.
引用
收藏
页数:5
相关论文
共 50 条
  • [1] Long term survival of cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy in advanced epithelial ovarian cancer
    Zhang, Jue
    Li, Xin-Bao
    Ma, Ru
    Ji, Zhong-He
    Bai, Wenpei
    Li, Yan
    TRANSLATIONAL CANCER RESEARCH, 2021, 10 (08) : 3705 - +
  • [2] Patterns of recurrence in women with advanced and recurrent epithelial ovarian cancer treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
    Chambers, Laura M.
    Yao, Meng
    Morton, Molly
    Gruner, Morgan
    Chichura, Anna
    Horowitz, Max
    Costales, Anthony B.
    Rose, Peter G.
    Michener, Chad M.
    Debernardo, Robert
    GYNECOLOGIC ONCOLOGY, 2021, 161 (02) : 389 - 395
  • [3] Secondary cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for recurrent epithelial ovarian cancer: a multi-institutional study
    Deraco, M.
    Virzi, S.
    Iusco, D. R.
    Puccio, F.
    Macri, A.
    Famulari, C.
    Solazzo, M.
    Bonomi, S.
    Grassi, A.
    Baratti, D.
    Kusamura, S.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2012, 119 (07) : 800 - 809
  • [4] Neoadjuvant Chemotherapy plus Interval Cytoreductive Surgery with or without Hyperthermic Intraperitoneal Chemotherapy (NIHIPEC) in the Treatment of Advanced Ovarian Cancer: A Multicentric Propensity Score Study
    Llueca, Antoni
    Ibanez, Maria Victoria
    Cascales, Pedro
    Gil-Moreno, Antonio
    Bebia, Vicente
    Ponce, Jordi
    Fernandez, Sergi
    Arjona-Sanchez, Alvaro
    Muruzabal, Juan Carlos
    Veiga, Nadia
    Diaz-Feijoo, Berta
    Celada, Cristina
    Gilabert-Estelles, Juan
    Aghababyan, Cristina
    Calero, Alicia
    Lacueva, Javier
    Segura, Juan Jose
    Maiocchi, Karina
    Llorca, Sara
    Villarin, Alvaro
    Climent, Maria Teresa
    Delgado, Katty
    Serra, Anna
    Gomez-Quiles, Luis
    Llueca, Maria
    CANCERS, 2023, 15 (17)
  • [5] Hyperthermic intraperitoneal chemotherapy with and without cytoreductive surgery for epithelial ovarian cancer
    Helm, C. William
    Bristow, Robert E.
    Kusamura, Shigeki
    Baratti, Dario
    Deraco, Marcello
    JOURNAL OF SURGICAL ONCOLOGY, 2008, 98 (04) : 283 - 290
  • [6] Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients with Advanced Ovarian Cancer: A 2-year Survival Analysis Study
    Farzaneh, Farah
    Ashtiani, Azadeh Jafari
    Bohlooli, Mehrdad
    Hosseini, Maryam Sadat
    CURRENT WOMENS HEALTH REVIEWS, 2024, 20 (04)
  • [7] Evaluation of Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy for Stage III Epithelial Ovarian Cancer
    Lei, Ziying
    Wang, Yue
    Wang, Jiahong
    Wang, Ke
    Tian, Jun
    Zhao, Ying
    Chen, Lipai
    Wang, Jin
    Luo, Jiali
    Jia, Manman
    Tang, Hongsheng
    He, Qingjun
    Liao, Quanxing
    Yang, Xiansheng
    Guan, Tianpei
    Wang, Li
    Cui, Shuzhong
    JAMA NETWORK OPEN, 2020, 3 (08) : E2013940
  • [8] Evaluating the Role of Hyperthermic Intraperitoneal Chemotherapy in Cytoreductive Surgery for Advanced-Stage Ovarian Cancer
    Kohut, Adrian
    Anderson, Matthew L.
    Andikyan, Vaagn
    Yasukawa, Maya
    Nguy, Lindsey
    Karachristos, Andreas
    Nywening, Timothy
    Mor, Gil
    Gogoi, Radhika
    Cohen, Joshua G.
    Lin, Jeff F.
    Rutherford, Thomas J.
    ANNALS OF SURGICAL ONCOLOGY, 2025, : 4326 - 4334
  • [9] Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in epithelial ovarian cancer: State of the art
    Ramez N Eskander
    Luca Ansaloni
    Robert E Bristow
    Federico Coccolini
    World Journal of Obstetrics and Gynecology, 2013, (04) : 94 - 100
  • [10] Cytoreductive Surgery plus Hyperthermic Intraperitoneal Chemotherapy Improves Survival with Acceptable Safety for Advanced Ovarian Cancer: A Clinical Study of 100 Patients
    Zhang, Jue
    Li, Xin-bao
    Ji, Zhong-he
    Ma, Ru
    Bai, Wen-pei
    Li, Yan
    BIOMED RESEARCH INTERNATIONAL, 2021, 2021